ARCHIVES

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 26 No. 38 | October 20, 2000

Download PDF Visit The Full Archive

Related Articles

WHT Participants Get “Phase Out” Help

March 11, 1988

NCI’s SBIR Paylines Nears Regular Grants

September 20, 1985

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

July 3, 1981

In Brief: Richard Fisher Named Fox Chase President and CEO

August 2, 2013

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

April 27, 2012

Oncology Management: US Oncology To Conduct Up To 5 Studies Of PG-TXL In Colorectal, Lung Cancers

June 1, 2001